Barinthus Biotherapeutics shows Oxford Science Enterprises plc at 0.0% ownership in a passive stake amendment, alongside a transaction involving 8,797,770 shares at $0.11 per share. The record gives investors both the reported ownership position and the transaction’s stated per-share value.

Key Highlights

  • Oxford Science Enterprises plc is identified in a transaction involving 8,797,770 Barinthus shares at $0.11 per share.
  • Oxford Science Enterprises’ amendment is dated 09/09/2026, while its signature is dated 09/11/2026.
  • Oxford Science Enterprises plc reported 0.0% ownership of Barinthus Biotherapeutics plc.
  • The passive stake amendment was filed under Rule 13d-1(d), with England, United Kingdom, listed as the jurisdiction.

Barinthus Biotherapeutics plc. is shown with a 0.0% position for Oxford Science Enterprises plc in a passive stake amendment.

Passive Stake Record Sets Out Ownership and Transaction Details

Oxford Science Enterprises plc appears as the reporting person under Rule 13d-1(d), with the amendment recording 0.0% ownership. The record identifies England, United Kingdom, as its Jurisdiction and dates the amendment 09/09/2026. Antonia Jenkinson signed for Oxford Science Enterprises in the capacity of chief financial officer on 09/11/2026. The transaction note identifies Oxford Science Enterprises as an insider of Barinthus Biotherapeutics and gives the per-share amount as $0.11.